| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |